Contrast-enhanced ultrasonography in the follow-up of patients with hepatic metastases from breast carcinoma;Ecografia con mezzo di contrasto nel follow-up di pazienti con metastasi epatiche da carcinoma mammario

Radiologia Medica

Volumn 112, Issue 1, 2007, Pages 47-55

  Della Vigna, P ^a   Cernigliaro, F ^b   Monfardini, L ^a   Gandini, S ^a   Bellomi, M ^a,c  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer; Contrast enhanced ultrasound; Liver metastasis; Ultrasound contrast agent

Indexed keywords

ACCURACY; ANALYTIC METHOD; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; FATTY LIVER; FOLLOW UP; HUMAN; LIVER METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY;

BREAST NEOPLASMS; CARCINOMA; CONTRAST MEDIA; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER CIRCULATION; LIVER NEOPLASMS; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SULFUR HEXAFLUORIDE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33847682237     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-007-0119-7     Document Type: Article

References (19)

1. Cai Q, Bensen M, Greene R et al (2000) Tamoxifen-induced transient multifocal hepatic fatty infiltration. Am J Gastroenterol 95:277-279
2. Norum J (1995) 5-Fluorouracil/levamisole induced intrahepatic fat infiltration imitating liver metastasis. Acta Oncol 34:971-972
3. Nishino M, Hayakawa K, Nakamura Y et al (2003) Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR Am J Roentgenol 180:129-134
4. Bruno S, Maisonneuve P, Castellana P et al (2005) Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. BMJ 330:932
5. Nies C, Leppek R, Sitter H et al (1996) Prospective evaluation of different diagnostic techniques for the detection of liver metastases at the time of primary resection of colorectal carcinoma. Eur J Surg 162:811-816
6. Zerhouni EA, Rutter C, Hamilton SR et al (1996) CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 200:443-451
7. Itai Y, Saida Y (2002) Pitfalls in liver imaging. Eur Radiol 12:1162-1174
8. Albrecht T, Hohmann J, Oldenburg A et al (2004) Detection and characterisation of liver metastases. Eur Radiol 14:25-33
9. Nicolau C, Bru C (2004) Focal liver lesions: evaluation with contrast-enhanced ultrasonography. Abdom Imaging 29:348-359
10. Prasad SR, Saini S, Sumner JE et al (2003) Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines. J Comput Assist Tomogr 27:380-384
11. Joseph A.E, Saverymuttu SH, al-Sam S et al (1991) Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 43:26-31
12. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
13. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310
14. Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8:135-160
15. Passamonti M, Vercelli A, Azzaretti A et al (2005) Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT. Radiol Med 109:358-369
16. Morel DR, Schwieger I, Hohn L et al (2000) Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 35:80-85
17. D'Onofrio M, Rozzanigo U, Masinielli BM et al (2005) Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography. J Clin Ultrasound 33:164-172
18. World health Organization (1979) WHO handbook for reporting result of cancer treatment. Offset Publication, Geneva CH
19. Bellomi M, Preda L (2004) La valutazione della risposta alla terapia delle lesioni neoplastiche Radiol Med 107:450-458